According to AlphaMoat, in 2026-08 Subsense (subsense-bci.com) received 9,354 monthly visits (+31.7% MoM) — ranked #10,088 of 17,407 AI websites with traffic data, and #1,542 of 3,173 in Industry Services; its largest market is United States (90.8% of visits).
What is Subsense
Subsense is building what it calls NanoBCI, a non-surgical brain-computer interface platform that the website says is the first nanoparticle-based BCI, using two types of in-brain nanoparticles with a wearable headset to form a scalable platform that connects the human brain, technology, and AI to improve treatment of neurological disease.
- 01The technology stack is structured in four layers: non-surgical entry into the brain via nasal delivery, targeted positioning and controllable navigation of nanoparticles to brain regions, and a bidirectional read-write device with precise external control
- 02biocompatible nanoparticles act as antennas that read and write neural signals, while wearable hardware handles wireless connection and control. The website's first stated direction is medical—accessible, safe neuromodulation and neural-readout options for neurological diseases such as Parkinson's and drug-resistant epilepsy—citing scale figures such as over 6,000,000 Parkinson's patients, over 20,000,000 with drug-resistant epilepsy, and a potential beneficiary population of over 3,000,000,000. The company says it starts with strictly controlled clinical and research settings to gradually build safety, efficacy, and trust
12-Month Traffic Trend
Visits by Country · Top 5
Popular in Industry Services
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.